(Q45309415)

12 December 2017

title

The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects (English)

1 reference

12 December 2017

0 references

1 reference

cardiovascular disease

1 reference

Vidal J

1

1 reference

12 December 2017

Morínigo R

2

1 reference

12 December 2017

Codoceo VH

3

1 reference

12 December 2017

Casamitjana R

4

1 reference

12 December 2017

Pellitero S

5

1 reference

12 December 2017

Gomis R

6

1 reference

12 December 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

International Journal of Obesity

12 December 2017

published in

1 reference

12 December 2017

volume

29

1 reference

12 December 2017

issue

6

1 reference

12 December 2017

page(s)

668-674

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

12 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

A comparison of the prevalence of the metabolic syndrome using two proposed definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

The metabolic syndrome in treatment-seeking obese persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Obesity, Metabolic Syndrome, and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Prognostic value of the metabolic syndrome in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Coronary heart disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Impaired glucose tolerance and cardiovascular disease: the possible role of post-prandial hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

7 January 2021

Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

7 January 2021

Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

7 January 2021

A clinical view of the obesity problem

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

7 January 2021

Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802921

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0802921

1 reference

Dimensions Publication ID

12 December 2017

1051733365

0 references

1 reference